97178 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD106
ENGINEERING METHOD FOR MESENCHYMAL STEM CELLS BASED ON POLYVALENT ANTIBODY AND APPLICATION THEREOF
#2Targeted Therapeutic Lipid Nanoparticles and Methods of Use
#3COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS
#4Methods of treatment by targeting VCAM1 and MAEA
#5DIABETES THERAPY TARGETING ABNORMAL STEM CELLS
#6THERAPY FOR DIABETES USING STEM CELL MIGRATION AGENT
#7TREATING CHRONIC LIVER DISEASE
#8Activatable anti-VEGF scFv
#9MODULATION OF LEUKOCYTE ACTIVITY IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE
#10Compositions and methods of treating cancer with chimeric antigen receptors
#11COMPOSITIONS AND METHODS FOR TARGETED CONTRAST AGENTS FOR MOLECULAR IMAGING
#12LANTHANIDE NANOP ARTICLE BASED FLUOROPHORES
#13Methods of treatment by targeting VCAM1 and MAEA
#14Methods for targeted delivery of agents to degraded elastic fibers
#15Methods of treatment by targeting VCAM1 and MAEA
#16Methods for detecting sinusoidal obstructive syndrome (SOS)
#17ERYTHROPOIETIC ROLE OF RESIDENT MACROPHAGES IN HEMATOPOIETIC ORGANS
#18Compositions and methods for TCR reprogramming using fusion proteins
#19Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties
#20COMPOSITIONS AND METHODS FOR TARGETED CONTRAST AGENTS FOR MOLECULAR IMAGING
#21COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#22Formation of delivery agents targeted to degraded elastic fibers
#23COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#24COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#25Activatable binding polypeptides and methods of identification and use thereof
#26Method and device for producing crude copper
#27Antibodies against CD106 (VCAM-1)
#28Combination therapy for the treatment of cancer using an anti-C-met antibody
#29Angiogenic and Immunologic Applications of Anti-CD160 Specific Compounds Obtainable From mAb CL1-R2
#30Antibodies cross-reactive to human and mouse c-Met and uses thereof
#31Treating macular degeneration using antibodies to aminophospholipids
#32Anti-VCAM-1 nanobodies
#33Activatable binding polypeptides and methods of identification and use thereof
#34Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#35Human monoclonal antibody that specifically binds to VCAM-1 and a composition for treating an inflammatory disease or a cancer comprising the same
#36Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
#37Activatable binding polypeptides and methods of identification and use thereof
#38Activatable binding polypeptides and methods of identification and use thereof
#39Activatable binding polypeptides and methods of identification and use thereof
#40Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
#41Compositions and methods of treating inflammatory bowel disease
#42COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#43Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
#44Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
#45Methods For Treating Diseases Using Antibodies to Aminophospolipids
#46Liposomes comprising duramycin and anti-viral agents
#47Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
#48METHOD FOR TREATING A VCAM-1 MEDIATED DISEASE
#49Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#50COMPOSITIONS AND METHODS FOR STEM CELL DELIVERY
#51Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2
#52ACTIVATABLE BINDING POLYPEPTIDES AND METHODS OF IDENTIFICATION AND USE THEREOF
#53Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
#54VCAM-1 specific monoclonal antibody
#55Suppression of xenotransplant rejection
#56Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
#57Compositions and methods for stem cell delivery
#58Cancer treatment kits using antibodies to aminophospholipids
#59Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids
#60Targeting and tracking of cells to specific organs and tissues in vivo
#61Suppression of xenotransplant rejection
#62Cancer treatment methods using selected antibodies to aminophospholipids
#63Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids
#64Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents
#65Combined cancer treatment methods using selected antibodies to aminophospholipids
#66Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
#67Combinations and kits for cancer treatment using selected antibodies to aminophospholipids